Benlabiod C., Psaila B.

In this issue of Blood, Reis et al1 identify a monoclonal antibody, INCA033989, that selectively targets mutant calreticulin (mutCALR) in myeloproliferative neoplasms (MPNs), inhibiting its oncogenic activity without affecting normal hematopoiesis.

INCA033989: the first shot on goal for MPNs?

Benlabiod C., Psaila B.

DOI

Type

Journal

Publication Date

Volume

Pages